- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jubilant Pharmova Limited — Updates, 31-10-2025: Press Release
31-10-2025 | 01:10 pm
31-10-2025 | 01:10 pm
Jubilant Pharmova's Q2 revenue grew 12% YoY to 1,966 Cr, PAT rose 21% to 124 Cr. The new CDMO Sterile Injectables line generates revenue, boosted by US tariff shifts, accelerating utilization. Radiopharma's Ruby-Fill® installs surged. API business transferred to Jubilant Biosys. Net Debt/EBITDA is 1.5x due to growth investments.
No comments yet. Be the first to comment!